Timing of hyperoxic exposure during alveolarization influences damage mediated by leukotrienes

J S Manji1, C J O'Kelly, W I Leung

  • 1Department of Physiology, University of Alberta, Edmonton, Alberta T6G 2S2, Canada.

Insights

Hyperoxia exposure during rat pup alveolar development impairs lung growth. Leukotrienes (LTs) mediate this, with sensitivity peaking around postnatal day 9, impacting alveolarization.

Area of Science:

  • Neonatal Physiology
  • Pulmonary Development
  • Pharmacology

Background:

  • Hyperoxia exposure during early life retards alveolar development.
  • Leukotrienes (LTs) are implicated in hyperoxia-induced lung injury.
  • The timing of hyperoxic insult may influence its impact on lung development.

Purpose of the Study:

  • To investigate the effects of hyperoxia during specific developmental windows on alveolarization.
  • To determine the relationship between oxygen exposure and leukotriene levels during alveolar development.
  • To assess the role of leukotriene synthesis inhibition in mitigating hyperoxic lung injury.

Main Methods:

  • Rat pups were exposed to hyperoxia (>95% O(2)) during distinct postnatal periods (days 1-4, 4-9, 9-14, or 4-14).
  • Some pups received a leukotriene (LT) synthesis inhibitor (MK-0591).
  • Alveolar development and lung tissue LT output were assessed on specific days.

Main Results:

  • Exposure from postnatal days 4-9 caused the most significant inhibition of alveolarization.
  • Hyperoxia increased leukotriene levels, particularly on days 9 and 14.
  • Inhibiting LT synthesis during hyperoxic exposure prevented impaired alveolar development.

Conclusions:

  • Alveolar development exhibits time-sensitive vulnerability to hyperoxia, particularly around postnatal day 9.
  • Leukotrienes play a critical role in mediating hyperoxia-induced retardation of alveolarization.
  • Targeting leukotriene pathways may offer a therapeutic strategy against hyperoxic lung injury in neonates.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.